Disintegrins in health and disease

Frontiers in Bioscience

Volumn 13, Issue 17, 2008, Pages 6617-6637

  McLane, Mary Ann ^a   Joerger, Torsten ^a   Mahmoud, Alaa ^a  

^a UNIVERSITY OF DELAWARE   (United States)

Author keywords

Cancer; Disintegrin; Evolution; Genomics; Integrin; Intracellular Signaling; Molecular; Proteomics; Review; Transcriptomics; Viper Venom

Indexed keywords

ANIMALIA; BACTERIA (MICROORGANISMS); SERPENTES; VIPERINAE; YERSINIA;

DISINTEGRIN;

ANIMAL; ANIMAL MODEL; CELL ADHESION; CELL MOTION; CHEMISTRY; CRYSTALLOGRAPHY; DRUG EFFECT; GENERAL ASPECTS OF DISEASE; GENETICS; HEALTH; HUMAN; LEUKOCYTE; NEOPLASM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSIOLOGY; REVIEW;

ANIMALS; CELL ADHESION; CELL MOVEMENT; CRYSTALLOGRAPHY; DISEASE; DISINTEGRINS; HEALTH; HUMANS; LEUKOCYTES; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, ANIMAL; NEOPLASMS;

EID: 52049111824     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: None     Document Type: Article

References (117)

1. M. A. McLane, E. E. Sanchez, A. Wong, C. Paquette-Straub and J. C. Perez: Disintegrins. Current drug targets: Cardiovasc Haematol Disorders 4, 327-355 (2004) (Pubitemid 39562089)
2. M. A. McLane, C. Marcinkiewicz, S. Vijay-Kumar, I. Wierzbicka-Patynowski and S. Niewiarowski: Viper venom disintegrins and related molecules. Proc Soc Exp Biol Med 219, 109-119 (1998)
3. R. M. Kini and H. J. Evans: Structural domains in venom proteins: evidence that metalloproteinases and nonenzymatic platelet aggregation inhibitors (disintegrins) from snake venoms are derived by proteolysis from a common precursor. Toxicon 30, 265-293 (1992)
4. D. Okuda, H. Koike and T. Morita: A new gene structure of the disintegrin family: a subunit of dimeric disintegrin has a short coding region. Biochemistry 41, 14248-14254 (2002) (Pubitemid 35403344)
5. F. S. Markland Jr: Snake venom fibrinogenolytic and fibrinolytic enzymes: an updated inventory. Registry of Exogenous Hemostatic Factors of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haem 79, 668-674 (1998)
6. A. Bazaa, N. Marrakchi, M. El Ayeb, L. Sanz and J. J. Calvete: Snake venomics: comparative analysis of the venom proteomes of the Tunisian snakes Cerastes cerastes, Cerastes vipera and Macrovipera lebetina. Proteomics 5, 4223-4235 (2005) (Pubitemid 41626090)
7. P. Juarez, S. C. Wagstaff, L. Sanz, R. A. Harrison and J. J. Calvete: Molecular cloning of Echis ocellatus disintegrins reveals non-venom-secreted proteins and a pathway for the evolution of ocellatusin. J Mol Evol 63, 183-193 (2006) (Pubitemid 44126974)
8. L. Sanz, R. Chen, A. Parez, R. Hilario, P. Juarez, C. Marcinkiewicz, D. Monlean, B. Celda, Y. Xiong, E. Parez-Paya and J. J. Calvete: cDNA cloning and functional expression of jerdostatin, a novel RTSdisintegrin from Trimeresurus jerdonii and a specific antagonist of the alpha1beta1 integrin. J Biol Chem 280, 40714-40722 (2005) (Pubitemid 41780562)
9. S. Bilgrami, S. Yadav, P. Kaur, S. Sharma, M. Perbandt, C. Betzel and T. P. Singh: Crystal structure of the disintegrin heterodimer from saw-scaled viper (Echis carinatus) at 1.9 A resolution. Biochemistry 44, 11058-11066 (2005) (Pubitemid 41209041)
10. A. Bazaa, P. Juarez, N. Marrakchi, Z. Bel Lasfer, M. El Ayeb, R. A. Harrison, J. J. Calvete and L. Sanz: Loss of introns along the evolutionary diversification pathway of snake venom disintegrins evidenced by sequence analysis of genomic DNA from Macrovipera lebetina transmediterranea and Echis ocellatus. J Mol Evol 64, 261-271 (2007) (Pubitemid 46147049)
11. L. Sanz, H. L. Gibbs, S. P. Mackessy and J. J. Calvete: Venom proteomes of closely related Sistrurus rattlesnakes with divergent diets. J Prot Res 5, 2098-2112 (2006) (Pubitemid 44330802)
12. J. J. Calvete, C. Marcinkiewicz and L. Sanz: Snake venomics of Bitis gabonica gabonica. Protein family composition, subunit organization of venom toxins, and characterization of dimeric disintegrins bitisgabonin-1 and bitisgabonin-2. J Prot Res 6, 326-336 (2007) (Pubitemid 46173684)
13. L. Sanz, A. Bazaa, N. Marrakchi, A. Perez, M. Chenik, Z. Bel Lasfer, M. El Ayeb and J. J. Calvete: Molecular cloning of disintegrins from Cerastes vipera and Macrovipera lebetina transmediterranea venom gland cDNA libraries: insight into the evolution of the snake venom integrin-inhibition system. Biochem J 395, 385-392 (2006)
14. B. G. Fry, H. Scheib, L. van der Weerd, B. Young, J. McNaughtan, S. F. Ramjan, N. Vidal, R. E. Poelmann and J. A. Norman: Evolution of an arsenal: Structural and functional diversification of the venom system in the advanced snakes (Caenophidia). Mol Cell roteomics 7 (2):215-246 (2008) (Pubitemid 351298438)
15. L. Qinghua, Z. Xiaowei, Y. Wei, L. Chenji, H. Yijun, Q. Pengxin, S. Xingwen, H. Songnian and Y. Guangmei: A catalog for transcripts in the venom gland of the Agkistrodon acutus: identification of the toxins potentially involved in coagulopathy. Biochem Biophys Res Comm 341, 522-531 (2006) (Pubitemid 43152136)
16. J. G. Soto, S. A. White, S. R. Reyes, R. Regalado, E. E. Sanchez and J. C. Perez: Molecular evolution of PIIISVMP and RGD disintegrin genes from the genus Crotalus. Gene 389, 66-72 (2007) (Pubitemid 46111020)
17. O. H. Ramos, A. Kauskot, M. R. Cominetti, I. Bechyne, C. L. Salla Pontes, F. Chareyre, J. Manent, R. Vassy, M. Giovannini, C. Legrand, H. S. Selistre-de-Araujo, M. Crepin and A. Bonnefoy: A novel alpha (v)beta (3)-blocking disintegrin containing the RGD motive, DisBa-01, inhibits bFGF-induced angiogenesis and melanoma metastasis. Clin Exp Met 25, 53-64 (2008) (Pubitemid 351191225)
18. P. Juarez, S. C. Wagstaff, J. Oliver, L. Sanz, R. A. Harrison and J. J. Calvete: Molecular cloning of disintegrin-like transcript BA-5A from a Bitis arietans venom gland cDNA library: a putative intermediate in the evolution of the long-chain disintegrin bitistatin. J Mol Evol 63, 142-152 (2006) (Pubitemid 43992013)
19. J. P. Xiong, T. Stehle, R. Zhang, A. Joachimiak, M. Frech, S. L. Goodman and M. A. Arnaout: Crystal structure of the extracellular segment of integrin alpha V beta 3 in complex with an Arg-Gly-Asp ligand. Science 296, 151-155 (2002) (Pubitemid 34280076)
20. D. Okuda, C. Nozaki, F. Sekiya and T. Morita: Comparative biochemistry of disintegrins isolated from snake venom: consideration of the taxonomy and geographical distribution of snakes in the genus Echis. J Biochem 129, 615-620 (2001) (Pubitemid 32299284)
21. R. Chen, Y. Jin, J. Wu, X. Zhou, Q. Lu, W. Wang and Y. Xiong: A new protein structure of P-II class snake venom metalloproteinases: it comprises metalloproteinase and disintegrin domains. Biochem Biophys Res Comm 310, 182-187 (2003) (Pubitemid 37162780)
22. S. H. Wang, X. C. Shen, G. Z. Yang and X. F. Wu: cDNA cloning and characterization of Agkistin, a new metalloproteinase from Agkistrodon halys. Biochem Biophys Res Comm, 301, 298-303 (2003) (Pubitemid 36279237)
23. P. Singhamatr and P. Rojnuckarin: Molecular cloning of albolatin, a novel snake venom metalloprotease from green pit viper (Trimeresurus albolabris), and expression of its disintegrin domain. Toxicon (2007)
24. J. W. Fox and S. M. Serrano: Structural considerations of the snake venom metalloproteinases, key members of the M12 reprolysin family of metalloproteinases. Toxicon 45, 969-985 (2005) (Pubitemid 40732574)
25. A. Ren, S. Wang, W. Cai, G. Yang, Y. Zhu, X. Wu and Y. Zhang: Agkistin-s, a disintegrin domain, inhibits angiogenesis and induces BAECs apoptosis. J Cell Biochem 99, 1517-1523 (2006) (Pubitemid 44845712)
26. J. J. Calvete, M. P. Moreno-Murciano, R. D. Theakston, D. G. Kisiel and C. Marcinkiewicz: Snake venom disintegrins: novel dimeric disintegrins and structural diversification by disulphide bond engineering. Biochem J 372, 725-734 (2003) (Pubitemid 36760386)
27. D. Monleon, M. P. Moreno-Murciano, H. Kovacs, C. Marcinkiewicz, J. J. Calvete and B. Celda: Concerted motions of the integrin-binding loop and the C-terminal tail of the non-RGD disintegrin obtustatin. J Biol Chem 278, 45570-45576 (2003) (Pubitemid 37432698)
28. V. Saudek, R. A. Atkinson, P. Lepage and J. T. Pelton: The secondary structure of echistatin from 1H-NMR, circular-dichroism and Raman spectroscopy. Europ J Biochem 202, 329-338 (1991)
29. H. Senn and W. Klaus: The nuclear magnetic resonance solution structure of flavoridin, an antagonist of the platelet GP IIb-IIIa receptor. J Mol Biol 232, 907-925 (1993) (Pubitemid 23256982)
30. K. J. Smith, M. Jaseja, X. Lu, J. A. Williams, E. I. Hyde and I. P. Trayer: Three-dimensional structure of the RGDcontaining snake toxin albolabrin in solution, based on 1H NMR spectroscopy and simulated annealing calculations. Inter J Pept Prot Res 48, 220-228 (1996)
31. M. Adler, R. A. Lazarus, M. S. Dennis and G. Wagner: Solution structure of kistrin, a potent platelet aggregation inhibitor and GP IIb-IIIa antagonist. Science 253, 445-448 (1991) (Pubitemid 21917174)
32. D. Monleon, V. Esteve, H. Kovacs, J. J. Calvete and B. Celda: Conformation and concerted dynamics of the integrin-binding site and the C-terminal region of echistatin revealed by homonuclear NMR. Biochem J 387, 57-66 (2005) (Pubitemid 40524074)
33. D. Yahalom, A. Wittelsberger, D. F. Mierke, M. Rosenblatt, J. M. Alexander and M. Chorev: Identification of the principal binding site for RGD-containing ligands in the alpha (V)beta (3) integrin: a photoaffinity cross-linking study. Biochemistry 41, 8321-8331 (2002) (Pubitemid 34705485)
34. I. Wierzbicka-Patynowski, S. Niewiarowski, C. Marcinkiewicz, J. J. Calvete, M. M. Marcinkiewicz and M. A. McLane: Structural requirements of echistatin for the recognition of alpha (v)beta (3) and alpha (5)beta (1) integrins. J Biol Chem 274, 37809-37814 (1999) (Pubitemid 30026844)
35. Y. Fujii, D. Okuda, Z. Fujimoto, K. Horii, T. Morita and H. Mizuno: Crystal structure of trimestatin, a disintegrin containing a cell adhesion recognition motif RGD. J Mol Biol 332, 1115-1122 (2003) (Pubitemid 37108803)
36. S. Bilgrami, S. Tomar, S. Yadav, P. Kaur, J. Kumar, T. Jabeen, S. Sharma and T. P. Singh: Crystal structure of schistatin, a disintegrin homodimer from saw-scaled viper (Echis carinatus) at 2.5 A resolution. J Mol Biol 341, 829-837 (2004) (Pubitemid 39127410)
37. J. J. Calvete, M. Jurgens, C. Marcinkiewicz, A. Romero, M. Schrader and S. Niewiarowski: Disulphidebond pattern and molecular modelling of the dimeric disintegrin EMF-10, a potent and selective integrin alpha5beta1 antagonist from Eristocophis macmahoni venom. Biochem J 345 Pt 3, 573-581 (2000) (Pubitemid 30099087)
38. M. R. Ritter, Q. Zhou and F. S. Markland Jr: Contortrostatin, a homodimeric disintegrin, actively disrupts focal adhesion and cytoskeletal structure and inhibits cell motility through a novel mechanism. Cell Comm Adhes 8, 71-86 (2001)
39. J. Shin, S. Hong, K. Chung, I. Kang, Y. Jang, D. Kim and W. Lee: Solution structure of a novel disintegrin, salmosin, from Agkistrondon halys venom. Biochemistry 42, 14408-14415 (2003) (Pubitemid 37531985)
40. J. H. Fernandez, C. A. Silva, M. T. Assakura, A. C. M. Camargo and S. M. T. Serrano: Molecular cloning, functional expression, and molecular modeling of bothrostatin, a new highly active disintegrin from Bothrops jararaca venom. Biochem Biophys Res Comm 329, 457-464 (2005) (Pubitemid 40311767)
41. S. Swenson, F. Costa, R. Minea, R. P. Sherwin, W. Ernst, G. Fujii, D. Yang and F. S. Markland: Intravenous liposomal delivery of the snake venom disintegrin contortrostatin limits breast cancer progression. Mol Cancer Therap 3, 499-511 (2004) (Pubitemid 39193728)
42. T. Soszka, K. A. Knudsen, L. Beviglia, C. Rossi, A. Poggi and S. Niewiarowski: Inhibition of murine melanoma cell-matrix adhesion and experimental metastasis by albolabrin, an RGD-containing peptide isolated from the venom of Trimeresurus albolabris. Exp Cell Res 196, 6-12 (1991) (Pubitemid 121006364)
43. R. Yang, C. Tang, W. Chuang, T. Huang, H. Peng, T. Huang and W. Fu: Inhibition of tumor formation by snake venom disintegrin. Toxicon 45, 661-669 (2005) (Pubitemid 40381026)
44. R. J. Shebuski, D. R. Ramjit, G. R. Sitko, P. K. Lumma and V. M. Garsky: Prevention of canine coronary artery thrombosis with echistatin, a potent inhibitor of platelet aggregation from the venom of the viper, Echis carinatus. Thromb Haem 64, 576-581 (1990)
45. H. K. Gold, T. Yasuda, I. K. Jang, J. L. Guerrero, J. T. Fallon, R. C. Leinbach and D. Collen: Animal models for arterial thrombolysis and prevention of reocclusion. Erythrocyte-rich versus platelet-rich thrombus. Circulation 83, IV26-40 (1991)
46. P. L. Barker, S. Bullens, S. Bunting, D. J. Burdick, K. S. Chan, T. Deisher, C. Eigenbrot, T. R. Gadek, R. Gantzos and M. T. Lipari: Cyclic RGD peptide analogues as antiplatelet antithrombotics. J Med Chem 35, 2040-2048 (1992)
47. S. I. Kim, K. S. Kim, H. S. Kim, D. S. Kim, Y. Jang, K. H. Chung and Y. S. Park: Inhibitory effect of the salmosin gene transferred by cationic liposomes on the progression of B16BL6 tumors. Cancer Res 63, 6458-6462 (2003) (Pubitemid 37255197)
48. I. C. Kang, D. S. Kim, Y. Jang and K. H. Chung: Suppressive mechanism of salmosin, a novel disintegrin in B16 melanoma cell metastasis. Biochem Biophys Res Comm 275, 169-173 (2000) (Pubitemid 30663647)
49. S. Swenson, F. Costa, W. Ernst, G. Fujii and F. S. Markland: Contortrostatin, a snake venom disintegrin with anti-angiogenic and anti-tumor activity. Pathophy Haem Thromb 34, 169-176 (2005)
50. M. Trikha, W. E. Rote, P. J. Manley, B. R. Lucchesi and F. S. Markland: Purification and characterization of platelet aggregation inhibitors from snake venoms. Thromb Res 73, 39-52 (1994) (Pubitemid 24062503)
51. R. Minea, S. Swenson, F. Costa, T. C. Chen and F. S. Markland: Development of a novel recombinant disintegrin, contortrostatin, as an effective anti-tumor and anti-angiogenic agent. Pathophys Haem Thromb 34, 177-183 (2005) (Pubitemid 43760349)
52. L. K. Hallak, J. R. Merchan, C. M. Storgard, J. C. Loftus and S. J. Russell: Targeted measles virus vector displaying echistatin infects endothelial cells via alpha (v)beta3 and leads to tumor regression. Cancer Res 65, 5292-5300 (2005) (Pubitemid 40827341)
53. P. McQuade, L. C. Knight and M. J. Welch: Evaluation of 64Cu-and 125I-radiolabeled bitistatin as potential agents for targeting alpha v beta 3 integrins in tumor angiogenesis. Bioconj Chem 15, 988-996 (2004) (Pubitemid 39297819)
54. K. S. Kim, D. S. Kim, K. H. Chung and Y. S. Park: Inhibition of angiogenesis and tumor progression by hydrodynamic cotransfection of angiostatin K1-3, endostatin, and saxatilin genes. Canc Gene Ther 13, 563-571 (2006)
55. M. P. Moreno-Murciano, D. Monleon, J. J. Calvete, B. Celda and C. Marcinkiewicz: Amino acid sequence and homology modeling of obtustatin, a novel non-RGDcontaining short disintegrin isolated from the venom of Vipera lebetina obtusa. Prot Sci 12, 366-371 (2003) (Pubitemid 36120349)
56. C. Marcinkiewicz, P. H. Weinreb, J. J. Calvete, D. G. Kisiel, S. A. Mousa, G. P. Tuszynski and R. R. Lobb: Obtustatin: a potent selective inhibitor of alpha1beta1 integrin in vitro and angiogenesis in vivo. Cancer Res 63, 2020-2023 (2003) (Pubitemid 36538600)
57. K. Z. Olfa, L. Jose, D. Salma, B. Amine, S. A. Najet, A. Nicolas, L. Maxime, Z. Raoudha, M. Kamel, M. Jacques, S. Jean-Marc, A. Mohamed el and M. Naziha: Lebestatin, a disintegrin from Macrovipera venom, inhibits integrinmediated cell adhesion, migration and angiogenesis. Lab Invest 85, 1507-1516 (2005) (Pubitemid 41662335)
58. J. Tian, C. Paquette-Straub, E. H. Sage, S. E. Funk, V. Patel, D. Galileo and M. A. McLane: Inhibition of melanoma cell motility by the snake venom disintegrin eristostatin. Toxicon 49, 899-908 (2007) (Pubitemid 46678124)
59. I. Staniszewska, S. Zaveri, L. Del Valle, I. Oliva, V. L. Rothman, S. E. Croul, D. D. Roberts, D. F. Mosher, G. P. Tuszynski and C. Marcinkiewicz: Interaction of alpha9beta1 integrin with thrombospondin-1 promotes angiogenesis. Circ Res 100, 1308-1316 (2007) (Pubitemid 46742921)
60. S. Bazan-Socha, D. G. Kisiel, B. Young, R. D. Theakston, J. J. Calvete, D. Sheppard and C. Marcinkiewicz: Structural requirements of MLDcontaining disintegrins for functional interaction with alpha 4 beta 1 and alpha 9 beta1 integrins. Biochemistry 43, 1639-1647 (2004) (Pubitemid 38200570)
61. R. J. Gould, M. A. Polokoff, P. A. Friedman, T. F. Huang, J. C. Holt, J. J. Cook and S. Niewiarowski: Disintegrins: a family of integrin inhibitory proteins from viper venoms. Proc Soc Exp Biol Med 195, 168-171 (1990) (Pubitemid 20373198)
62. M. A. McLane, X. Zhang, J. Tian and C. Paquette-Straub: Monomeric and dimeric disintegrins: Platelet active agents from viper venom. Toxin Rev 25, 435-464 (2006)
63. D. Okuda and T. Morita: Purification and characterization of a new RGD/KGD-containing dimeric disintegrin, piscivostatin, from the venom of Agkistrodon piscivorus piscivorus: the unique effect of piscivostatin on platelet aggregation. J Biochem 130, 407-415 (2001) (Pubitemid 32845695)
64. K. Oshikawa and S. Terada: Ussuristatin 2, a novel KGD-bearing disintegrin from Agkistrodon ussuriensis venom. J Biochem 125, 31-35 (1999) (Pubitemid 29085958)
65. M. Pfaff, M. A. McLane, L. Beviglia, S. Niewiarowski and R. Timpl: Comparison of disintegrins with limited variation in the RGD loop in their binding to purified integrins alpha IIb beta 3, alpha V beta 3 and alpha 5 beta 1 and in cell adhesion inhibition. Cell Adh Comm 2, 491-501 (1994)
66. D. G. Kisiel, J. J. Calvete, J. Katzhendler, A. Fertala, P. Lazarovici and C. Marcinkiewicz: Structural determinants of the selectivity of KTS-disintegrins for the lpha1beta1 integrin. FEBS Lett 577, 478-482 (2004) (Pubitemid 39535335)
67. J. A. Galán, E. E. Sanchez, S. Bashir and J. C. Perez: Characterization and identification of disintegrins in Crotalus horridus venom by liquid chromatography and tandem matrix-assisted laser desorption ionization -quadrupole ion trap time-of-flight (MALDI-QIT-TOF) mass spectrometry. Can J Chem 83, 1124-1131 (2005) (Pubitemid 41783740)
68. E. E. Sánchez, J. A. Galán, W. K. Russell, J. G. Soto, D. H. Russell and J. C. Pérez: Isolation and characterization of two disintegrins inhibiting ADPinduced human platelet aggregation from the venom of Crotalus scutulatus scutulatus (Mohave Rattlesnake). Toxicol Appl Pharm, 212, 59-68 (2006)
69. R. M. Scarborough, M. A. Naughton, W. Teng, J. W. Rose, D. R. Phillips, L. Nannizzi, A. Arfsten, A. M. Campbell and I. F. Charo: Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa. J Biol Chem 268, 1066-1073 (1993) (Pubitemid 23019743)
70. J. Jing and S. Lu: Inhibition of platelet aggregation of a mutant proinsulin chimera engineered by introduction of a native Lys-Gly-Asp-containing sequence. Biotech Lett 27, 1259-1265 (2005) (Pubitemid 41428173)
71. R. R. Hantgan, M. C. Stahle, J. H. Connor, R. F. Connor and S. A. Mousa: AlphaIIbbeta3 priming and clustering by orally active and intravenous integrin antagonists. J Thromb Haem 5, 542-550 (2007) (Pubitemid 46680688)
72. J. Kim, S. Hong, H. Park, D. Kim and W. Lee: Structure and function of RGD peptides derived from disintegrin proteins. Mol Cells 19, 205-211 (2005)
73. S. Reiss, M. Sieber, V. Oberle, A. Wentzel, P. Spangenberg, R. Claus, H. Kolmar and W. Lasche: Inhibition of platelet aggregation by grafting RGD and KGD sequences on the structural scaffold of small disulfide-rich proteins. Platelets 17, 153 (2006)
74. A. Christmann, K. Walter, A. Wentzel, R. Kratzner and H. Kolmar: The cystine knot of a squash-type protease inhibitor as a structural scaffold for Escherichia coli cell surface display of conformationally constrained peptides. Prot Eng 12, 797-806 (1999) (Pubitemid 29472087)
75. J. C. McNulty, D. A. Thompson, K. A. Bolin, J. Wilken, G. S. Barsh and G. L. Millhauser: Highresolution NMR structure of the chemically-synthesized melanocortin receptor binding domain AGRP (87-132) of the agouti-related protein. Biochemistry 40, 15520-15527 (2001) (Pubitemid 34015179)
76. R. M. Scarborough, J. W. Rose, M. A. Naughton, D. R. Phillips, L. Nannizzi, A. Arfsten, A. M. Campbell and I. F. Charo: Characterization of the integrin specificities of disintegrins isolated from American pit viper venoms. J Biol Chem 268, 1058-1065 (1993) (Pubitemid 23019742)
77. D. Juliano, Y. Wang, C. Marcinkiewicz, L. A. Rosenthal, G. J. Stewart and S. Niewiarowski: Disintegrin interaction with alpha V beta 3 integrin on human umbilical vein endothelial cells: expression of ligand-induced binding site on beta 3 subunit. Exp Cell Res 225, 132-142 (1996)
78. S. Schmitmeier, F. S. Markland, A. H. Schonthal and T. C. Chen: Potent mimicry of fibronectin-induced intracellular signaling in glioma cells by the homodimeric snake venom disintegrin contortrostatin. Neurosurgery 57, 141-53 (2005) (Pubitemid 40944179)
79. S. Rahman, A. Aitken, G. Flynn, C. Formstone and G. F. Savidge: Modulation of RGD sequence motifs regulates disintegrin recognition of alphaIIb beta3 and alpha5 beta1 integrin complexes. Replacement of elegantin alanine-50 with proline, N-terminal to the RGD sequence, diminishes recognition of the alpha5 beta1 complex with restoration induced by Mn2+ cation. Biochem J 335 ( Pt 2), 247-257 (1998) (Pubitemid 28492699)
80. R. Sumathipala, C. Xu, J. Seago, A. P. Mould, M. J. Humphries, S. E. Craig, Y. Patel, E. S. Wijelath, M. Sobel and S. Rahman: The "linker" region (amino acids 38-47) of the disintegrin elegantin is a novel inhibitory domain of integrin alpha5beta1-dependent cell adhesion on fibronectin: evidence for the negative regulation of fibronectin synergy site biological activity. J Biol Chem 281, 37686-37696 (2006) (Pubitemid 46042072)
81. I. Staniszewska, I. K. Sariyer, S. Lecht, M. C. Brown, E. M. Walsh, G. P. Tuszynski, M. Safak, P. Lazarovici and C. Marcinkiewicz: Integrin {alpha}9{beta}1 is a receptor for nerve growth factor and other neurotrophins. J Cell Sci (2008)
82. E. Alimenti, S. Tafuri, A. Scibelli, D. D'Angelo, L. Manna, L. M. Pavone, M. A. Belisario and N. Staiano: Pro-apoptotic signaling pathway activated by echistatin in GD25 cells. Biochim Biophys Acta 1693, 73-80 (2004) (Pubitemid 38970137)
83. M. A. Belisario, S. Tafuri, G. Pontarelli, N. Staiano and E. Gionti: Modulation of chondrocyte adhesion to collagen by echistatin. Eur J Cell Biol 84, 833-842 (2005) (Pubitemid 41440015)
84. M. Li and D. S. Sakaguchi: Inhibition of integrinmediated adhesion and signaling disrupts retinal development. Devel Biol 275, 202-214 (2004) (Pubitemid 39298185)
85. B. P. Halloran, D. D. Bikle, C. M. Cone and E. Morey-Holton: Glucocorticoids and inhibition of bone formation induced by skeletal unloading. Amer J Physiol Endo Metab 255, E875-879 (1988)
86. T. Sakata, Y. Wang, B. P. Halloran, H. Z. Elalieh, J. Cao and D. D. Bikle: Skeletal unloading induces resistance to insulin-like growth factor-I (IGF-I) by inhibiting activation of the IGF-I signaling pathways. J Bone Miner Res 19, 436-446 (2004) (Pubitemid 38787399)
87. D. S. Kim, Y. Jang, O. Jeon and D. Kim: Saxatilin inhibits TNF-alpha-induced proliferation by suppressing AP-1-dependent IL-8 expression in the ovarian cancer cell line MDAH 2774. Mol Immunol 44, 1409-1416 (2007) (Pubitemid 44415952)
88. A. Surazynaski, P. Sienkiewicz, S. Wolczynski and J. Palka: Differential effects of echistatin and thrombin on collagen production and prolidase activity in human dermal fibroblasts and their possible implication in beta1-integrinmediated signaling. 51, 217-221 (2005)
89. S. F. Retta, G. Cassara, M. D'Amato, R. Alessandro, M. Pellegrino, S. Degani, G. De Leo, L. Silengo and G. Tarone: Cross talk between beta (1) and alpha (V) integrins: beta (1) affects beta (3) mRNA stability. Mol Biol Cell 12, 3126-3138 (2001)
90. C. Tang, R. Yang, T. Huang, D. Lu, W. Chuang, T. Huang and W. Fu: Ultrasound stimulates cyclooxygenase-2 expression and increases bone formation through integrin, focal adhesion kinase, phosphatidylinositol 3-kinase, and Akt pathway in osteoblasts. Mol Pharm 69, 2047-2057 (2006) (Pubitemid 43894324)
91. Y. Jang, O. Jeon and D. Kim: Saxatilin, a snake venom disintegrin, regulates platelet activation associated with human vascular endothelial cell migration and invasion. J Vasc Res 44, 129-137 (2007)
92. Y. J. Jang, D. S. Kim, O. H. Jeon and D. S. Kim: Saxatilin suppresses tumor-induced angiogenesis by regulating VEGF expression in NCI-H460 human lung cancer cells. J Biochem Mol Biol 40, 439-443 (2007)
93. Y. Tseng, H. Peng and T. Huang: Rhodostomin, a disintegrin, inhibits adhesion of neutrophils to fibrinogen and attenuates superoxide production. J Biochem Sci 11, 683-691 (2004) (Pubitemid 39179133)
94. A. L. J. Coelho, M. S. De Freitas, A. Mariano-Oliveira, D. C. M. Rapozo, L. F. R. Pinto, S. Niewiarowski, R. B. Zingali, C. Marcinkiewicz and C. Barja-Fidalgo: RGDand MLD-disintegrins, jarastatin and EC3, activate integrin-mediated signaling modulating the human neutrophils chemotaxis, apoptosis and IL-8 gene expression. Exp Cell Res 292, 371-384 (2004) (Pubitemid 38018852)
95. S. Bazan-Socha, A. Bukiej, G. Pulka, C. Marcinkiewicz and J. Musial: Increased expression of collagen receptors: alpha1beta1 and alpha2beta1 integrins on blood eosinophils in bronchial asthma. Clin Exp Allergy 36, 1184-1191 (2006) (Pubitemid 44342934)
96. E. H. Neto, A. L. Coelho, A. L. Sampaio, M. G. Henriques, C. Marcinkiewicz, M. S. De Freitas and C. Barja-Fidalgo: Activation of human T lymphocytes via integrin signaling induced by RGD-disintegrins. Biochim Biophys Acta 1773, 176-184 (2007) (Pubitemid 46151693)
97. D. S. Sun, S. J. Lo, C. H. Lin, M. S. Yu, C. Y. Huang, Y. F. Chen and H. H. Chang: Calcium oscillation and phosphatidylinositol 3-kinase positively regulate integrin alpha (IIb)beta3-mediated outside-in signaling. J Biomed Sci 12, 321-333 (2005) (Pubitemid 40897639)
98. Y. Lin, C. Tang, W. Chuang, S. Wang, T. Huang and W. Fu: Inhibition of adipogenesis by RGD-dependent disintegrin. Biochem Pharmacol 70, 1469-1478 (2005) (Pubitemid 41483457)
99. H. Leong-Poi, J. Christiansen, P. Heppner, C. W. Lewis, A. L. Klibanov, S. Kaul and J. R. Lindner: Assessment of endogenous and therapeutic arteriogenesis by contrast ultrasound molecular imaging of integrin expression. Circulation 111, 3248-3254 (2005) (Pubitemid 40874997)
100. R. R. Hantgan, M. C. Stahle, J. H. Connor, D. S. Lyles, D. A. Horita, M. Rocco, C. Nagaswami, J. W. Weisel and M. A. McLane: The disintegrin echistatin stabilizes integrin alphaIIbbeta3's open conformation and promotes its oligomerization. J Mol Biol 342, 1625-636 (2004) (Pubitemid 39208683)
101. R. R. Hantgan, M. C. Stahle and D. A. Horita: Entropy drives integrin alphaIIbbeta3: Echistatin bindingevidence from surface plasmon resonance spectroscopy. Biochemistry (2008)
102. A. Scibelli, G. Matteoli, S. Roperto, E. Alimenti, L. Dipineto, L. M. Pavone, R. Della Morte, L. F. Menna, A. Fioretti and N. Staiano: Flavoridin inhibits Yersinia enterocolitica uptake into fibronectin-adherent HeLa cells. FEMS Micro Lett 247, 51-57 (2005) (Pubitemid 40779464)
103. A. Bayes-Genis, R. S. Schwartz, L. K. Bale and C. A. Conover: Effects of insulin-like growth factor-I on cultured human coronary artery smooth muscle cells. Growth Horm IGF Res 13, 246-253 (2003) (Pubitemid 37161678)
104. S. Kapur, S. Mohan, D. J. Baylink and K. H. Lau: Fluid shear stress synergizes with insulin-like growth factor-I (IGF-I) on osteoblast proliferation through integrindependent activation of IGF-I mitogenic signaling pathway. J Biol Chem 280, 20163-20170 (2005) (Pubitemid 41379548)
105. H. Sekimoto, J. Eipper-Mains, S. Pond-Tor and C. M. Boney: (alpha)v (beta)3 integrins and Pyk2 mediate insulin-like growth factor I activation of Src and mitogenactivated protein kinase in 3T3-L1 cells. Mol Endo 19, 1859-1867 (2005) (Pubitemid 41007897)
106. N. E. Fox and K. Kaushansky: Engagement of integrin alpha4beta1 enhances thrombopoietin-induced megakaryopoiesis. Exp Hem 33, 94-99 (2005) (Pubitemid 40127648)
107. K. O. Yee, Y. Ikari, S. Bodary and S. M. Schwartz: Kistrin inhibits human smooth muscle cell interaction with fibrin. Thromb Res 97, 39-50 (2000) (Pubitemid 30042903)
108. W. P. Sheffield, B. Wilson, L. J. Eltringham-Smith, S. Gataiance and V. Bhakta: Recombinant albumins containing additional peptide sequences smaller than barbourin retain the ability of barbourin-albumin to inhibit platelet aggregation. Thromb Haem 93, 914-921 (2005) (Pubitemid 40691550)
109. J. A. Marques, J. K. George, I. J. Smith, V. Bhakta and W. P. Sheffield: A barbourin-albumin fusion protein that is slowly cleared in vivo retains the ability to inhibit platelet aggregation in vitro. Thromb Haem 86, 902-908 (2001) (Pubitemid 32834203)
110. F. Frausin, V. Scarcia, M. Cocchietto, A. Furlani, B. Serli, E. Alessio and G. Sava: Free exchange across cells, and echistatin-sensitive membrane target for the metastasis inhibitor NAMI-A (imidazolium trans-imidazole dimethyl sulfoxide tetrachlororuthenate) on KB tumor ells. Pharm Exp Therap 313, 227-233 (2005) (Pubitemid 40411346)
111. D. Butera, K. Skielka, M. A. McLane, C. Paquette-Straub, F. Ducancel and A.M.M da Silva: Cloning, expression, and characterization of a bi-functional disintegrin/alkaline phosphatase hybrid protein. Prot Exp Purif 31, 286-291 (2003) (Pubitemid 37325578)
112. D. Butera, R. M. Piazza, M. A. McLane, R. Chammas and A. M. da Silva: Molecular engineering of an EGFP/disintegrin-based integrin marker. Toxicon 46, 178-184 (2005) (Pubitemid 40966046)
113. C. Ouyang, H. I. Yeh and T. F. Huang: A potent platelet aggregation inhibitor purified from Agkistrodon halys (mamushi) snake venom. Toxicon 21, 797-804 (1983) (Pubitemid 14206677)
114. C. Yeh, H. Peng, J. Yih and T. Huang: A new short chain RGD-containing disintegrin, accutin, inhibits the common pathway of human platelet aggregation. Biochem Biophys Acta 1425, 493-504 (1998) (Pubitemid 28546684)
115. J. B. Smith, R. D. Theakston, A. L. Coelho, C. Barja-Fidalgo, J. J. Calvete and C. Marcinkiewicz: Characterization of a monomeric disintegrin, ocellatusin, present in the venom of the Nigerian carpet viper, Echis ocellatus. FEBS Lett 512, 111-115 (2002) (Pubitemid 34164461)
116. A. L. Coelho, M. S. de Freitas, A. L. Oliveira-Carvalho, V. Moura-Neto, R. B. Zingali and C. Barja-Fidalgo: Effects of jarastatin, a novel snake venom disintegrin, on neutrophil migration and actin cytoskeleton dynamics. Exp Cell Res 251, 379-387 (1999) (Pubitemid 29431875)
117. T. Nikai, K. Taniguchi, Y. Komori, K. Masuda, J. W. Fox, H. Sugihara: Primary structure and functional characterization of bilitoxin-1, a novel dimeric P-II snake venom metalloproteinase from Agkistrodon bilineatus venom. Arch Biochem Biophys 378 (1), 6-15 (2000) (Pubitemid 30350458)